Julian Moran, BSc
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
KIM-1-mediated Proximal Tubular Uptake of Palmitic Acid-Albumin Leads to Progressive Diabetic Kidney Disease
